Investigative Radiology

Skip Navigation LinksHome > February 2011 - Volume 46 - Issue 2 > Double-Dose Gadoxetic Acid-Enhanced Magnetic Resonance Imagi...
Text sizing:
Investigative Radiology:
doi: 10.1097/RLI.0b013e3181f9c487
Original Article

Double-Dose Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients With Chronic Liver Disease

Motosugi, Utaroh MD, PhD*; Ichikawa, Tomoaki MD, PhD*; Sano, Katsuhiro MD, PhD*; Sou, Hironobu MD*; Onohara, Kojiro MD*; Muhi, Ali MB, ChB*; Kitamura, Takatoshi MD, PhD†; Amemiya, Fumitake MD, PhD†; Enomoto, Nobuyuki MD, PhD†; Matsuda, Masanori MD, PhD‡; Asakawa, Masami MD, PhD‡; Fujii, Hideki MD, PhD‡; Araki, Tsutomu MD, PhD*

Collapse Box


Objectives: To determine the effect of double-dose gadoxetic-acid (Gd-EOB-DTPA) on lesion-liver contrast ratio in arterial- and hepatocyte-phase images and arterial-phase image quality in patients with chronic liver disease.

Materials and Methods: The ethics committee at our institute approved this study. This study included 28 patients (13 with Child-Pugh class A and 15 with class B) with 54 hepatocellular carcinomas. All patients received the standard Gd-EOB-DTPA dose (0.025 mmol/kg bodyweight) and double dose (0.050 mmol/kg bodyweight). The lesion-liver contrast ratio was evaluated in arterial- and hepatocyte-phase images. The artifacts in arterial-phase images were evaluated with a 4-point scale. Wilcoxon signed-rank test were used for comparisons.

Results: The hepatocyte-phase lesion-liver contrast ratio after the double dose was significantly higher than that after the standard dose in patients with Child-Pugh class B disease(standard dose vs. double dose; 0.20 ± 0.16 vs. 0.25 ± 0.17; P < 0.0001); however, the ratio after both the standard and double doses was equivalent in patients with Child-Pugh class A disease (0.35 ± 0.18 vs. 0.35 ± 0.14; P = 0.3038). The double dose significantly increased the arterial-phase lesion-liver contrast ratio (0.34 ± 0.19 vs. 0.58 ± 0.33; P < 0.0001). The artifacts in the arterial-phase images were more prominent after the standard dose (2.7 vs. 2.4 for reader 1, 2.8 vs. 2.4 for reader 2; P = 0.0195 and 0.0010).

Conclusions: Administration of double dose of Gd-EOB-DTPA provided better arterial enhancement of hepatocellular carcinomas in patients with chronic liver disease, and also improved the lesion-liver contrast in hepatocyte-phase images in patients with Child-Pugh class B disease.

© 2011 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.